COMMUNIQUÉS West-GlobeNewswire

Immunocore strengthens IP position in the field of TCR-based therapeutics
05/09/2018
PRESS RELEASE Immunocore strengthens IP position in the field of TCR-based therapeutics Notice of Allowance received from US patent and trademark office relating to ImmTAC® platform (Oxford, UK and Conshohocken, US, 5 [...]
DBV Technologies, Geneva University Hospitals and BioNet-Asia Presented Additional Phase I Data on the Use of an Investigational Epicutaneous Patch in Boosting Pertussis Vaccination at the ECI
05/09/2018
DBV Technologies, Geneva University Hospitals and BioNet-Asia Presented Additional Phase I Data on the Use of an Investigational Epicutaneous Patch in Boosting Pertussis Vaccination at the European Congress of [...]
DBV, les HUG et BioNet ont présenté les données additionnelles d'une étude de phase I sur l'utilisation d'un patch épicutané expérimental en vaccination de rappel contre la coqueluche lors de l'ECI
05/09/2018
DBV Technologies, les Hôpitaux Universitaires de Genève et BioNet-Asia ont présenté les données additionnelles d'une étude de phase I sur l'utilisation d'un patch épicutané expérimental en vaccination de rappel contre [...]
MediciNova to Attend the Morgan Stanley Global Healthcare Conference in New York
05/09/2018
LA JOLLA, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
Veritas Appoints Lorne Mark Roseborough CEO of SunVault Energy to the Board of Directors
05/09/2018
VANCOUVER, British Columbia, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce the appointment of Lorne Mark [...]
CO2 GRO Inc. Engages a Senior Scientist in a Shares for Service Agreement
05/09/2018
TORONTO, Sept. 04, 2018 (GLOBE NEWSWIRE) -- CO2 GRO Inc. (“ CO2GRO ” or “ GROW ”) (TSX-V:GROW) announces that it has entered into an agreement with Dr. Luc Duchesne (“ Duchesne ”). Dr. Duchesne, PhD., Plant Biochemistry [...]
Agios Announces Chief Executive Officer Succession Plan
04/09/2018
- David Schenkein, M.D., Agios Long-Time Chief Executive Officer, to Become Executive Chairman, Effective February 1, 2019 - - Jacqualyn Fouse, Ph.D., to Succeed Dr. Schenkein as Chief Executive Officer - CAMBRIDGE, [...]
IMV Inc. Celebrates Grand Opening of New Facility in Dartmouth, Nova Scotia
04/09/2018
DARTMOUTH, Nova Scotia, Sept. 04, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, celebrated its grand opening today of its new facilities in Dartmouth, Nova [...]
Helix BioPharma Corp. collaborator ProMab Biotechnologies to present at the CAR-TCR Summit 2018 in Boston
04/09/2018
RICHMOND HILL, Ontario, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (FSE: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
BeiGene Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
04/09/2018
CAMBRIDGE, Mass., and BEIJING, China, Sept. 04, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
National Research Corporation Declares Quarterly Dividend
04/09/2018
Lincoln, Nebraska, Sept. 04, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 (seventeen cents) per share [...]
Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
04/09/2018
EMERYVILLE, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that [...]
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
04/09/2018
BOSTON, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]
SpeakEasy Announces Non-Brokered Private Placement
04/09/2018
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 04, 2018 (GLOBE NEWSWIRE) -- SpeakEasy Cannabis Club Ltd. (CSE: EASY) ( [...]
TESARO Announces Expansion to Second Stage of JASPER Trial of ZEJULA® in Combination With TSR-042 in Non-Small Cell Lung Cancer
04/09/2018
All evaluable patients experienced tumor shrinkage Protocol defined response criteria achieved and trial expansion ongoing WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO), an oncology- [...]
Retrophin Announces Proposed Convertible Senior Notes Offering
04/09/2018
SAN DIEGO, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced its intention to offer, subject to market and other conditions, $200 million aggregate principal amount of convertible senior [...]
Aduro Biotech and Dana-Farber Cancer Institute Publish Data Highlighting Immunosuppressive Impact of APRIL in Multiple Myeloma in Leukemia
04/09/2018
BERKELEY, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced the publication of a peer reviewed paper in Leukemia authored by scientists from the Dana Farber Cancer Institute [...]
Rubius Therapeutics to Participate in the Morgan Stanley 16th Annual Global Healthcare Conference
04/09/2018
CAMBRIDGE, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, announced today that [...]
Dova Pharmaceuticals Submits Supplemental New Drug Application for DOPTELET® (avatrombopag) for the Treatment of Chronic ITP
04/09/2018
DURHAM, N.C., Sept. 04, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA), a specialty pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for diseases where [...]

Pages